Wednesday, December 12, 2012
Today's meeting of the governing board of the California stem cell agency has adjourned. We will have an item coming up shortly on approval of $3 million for ViaCyte, Inc., of San Diego. Sphere: Related Content
With more than one million page views and more than 4,000 items, this blog provides news and commentary on public policy, business and economic issues related to the $3 billion California stem cell agency, officially known as the California Institute for Regenerative Medicine(CIRM). David Jensen, a retired California newsman, has published this blog since January 2005. His email address is email@example.com.
StemCells, Inc. stock price performance -- Google chart Highlights Layoffs, clinical trial closed Conflicts of interest Implications...